Regional News

Luye Pharma Announces U.S. FDA Approval of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for Treating Schizophrenia and Schizoaffective Disorder

PRINCETON, N.J., July 28, 2024 /PRNewswire/ -- Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sales of innovative medications, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's ERZOFRI® (pa...

2024-07-28 21:48 3020

AI illuminates a better life, DreamSmart officially opens at the 2024 ChinaJoy and AI Ecological Season

SHANGHAI, July 27, 2024 /PRNewswire/ -- On 26 July 2024, the DreamSmart AI Ecological Pavilion officially landed at the 2024 China International Digital Interactive Entertainment Exhibition (2024 ChinaJoy,Shanghai • New International Expo Center Snapdragon Theme Pavilion E4-05 Booth), presenti...

2024-07-28 02:07 3939

Mega Matrix announced that FlexTV App achieved the new milestone, surging into Top 8 on the Apple Store Entertainment Chart (Free Apps, Japan) as of July 26, 2024

PALO ALTO, Calif., July 26, 2024 /PRNewswire/ -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that FlexTV, its short drama streaming platform, surged into No.8. in the App Store Entertainment Apps (Free Apps,Japan) as of July 26, 2024.

2024-07-27 00:54 3011

WiMi Built an Advanced Data Structure Architecture Using Homomorphic Encryption and Federated Learning

BEIJING, July 26, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it utilized homomorphic encryption and federated learning building an advanced data structure arch...

2024-07-26 21:00 5323

ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders

BRISBANE, Calif., July 26, 2024 /PRNewswire/ -- ReviR Therapeutics, an AI-enabled biotechnology company focused on developing small molecule RNA modulators for neurogenetic diseases, announced today that it has successfully completed a$30 million Series A financing, bringing the total raised so f...

2024-07-26 21:00 3192

Azazie Unveils Fashion Forward Atelier Collection - "Secret Garden"

LOS ANGELES, July 26, 2024 /PRNewswire/ -- Azazie , the leading DTC e-tailer for all things bridal and occasion wear, is thrilled to announce the l...

2024-07-26 21:00 2077

CougarD Soars with 115% User Surge: New Video Verification Feature Drives Unprecedented Growth

WASHINGTON, July 26, 2024 /PRNewswire/ -- CougarD, a leading innovator in mature dating, is delighted to announce its outstanding performance for the first half of 2024. The company has achieved significant milestones, including a 115% increase in user registrations and a 91% rise in paid subscri...

2024-07-26 20:00 1939

Nature's Miracle Holding Inc. Announces Pricing of $1.2 Million Public Offering

ONTARIO, Calif., July 26, 2024 /PRNewswire/ -- Nature's Miracle Holding Inc. (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, today announced the pricing of a public offering of 5,000,000 units (the "Units") consisting of (i) one sh...

2024-07-26 20:00 4763

HanAll Biopharma Reports Q2 2024 Financial Results and Provides Business Update

* HanAll reports strong financial performance with second quarter total revenue of31.6 billion KRW, driven by the strong sales from the key products. * HanAll expands collaboration with Turn Biotechnologies through an exclusive licensing agreement for Epigenetic Reprogramming of Aging (ERATM) ...

2024-07-26 19:00 4545

GMIF2024 Innovation Summit Invites All to Gather in Shenzhen on September 27

SHENZHEN, China, July 26, 2024 /PRNewswire/ -- Driven by production cuts and price increases from upstream manufacturers, alongside a gradual revival in the consumer electronics market, the memory industry is witnessing a recovery after two years of supply-demand imbalance and significant price d...

2024-07-26 18:51 3965

Sanyou Bio Congratulates Eluminex Biosciences and Foreseen Biotechnology on Major Breakthroughs in Innovative Drug Project

SHANGHAI, July 26, 2024 /PRNewswire/ -- On July 15, Eluminex Biosciences announced that their tri-specific fusion antibody drug, EB-105, has administered its first dose to a diabetic macular edema patient inthe United States. This clinical trial, known as LOTUS, is an open-label, multicenter, si...

2024-07-26 18:00 3866

LightInTheBox to Report Second Quarter 2024 Financial Results on Friday, August 2, 2024

- Earnings Call Scheduled for 9:00 a.m. ET on August 2, 2024 - SINGAPORE, July 26, 2024 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), an apparel e-commerce retailer that ships products to consumers worldwide, today announced that it will release...

2024-07-26 18:00 6307

Bright Scholar Schedules Unaudited Financial Results for the Third Quarter of Fiscal 2024 Ended May 31, 2024

FOSHAN, China, July 26, 2024 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar," the "Company," "we" or "our") (NYSE: BEDU), a global premier education service company, today announced that it will release its unaudited financial results for the third quarter of fiscal 20...

2024-07-26 17:00 4443

Waterdrop Filter and The Water Project Partnership: Making a Difference in Communities through Access to Clean Water

LOS ANGELES, July 26, 2024 /PRNewswire/ -- Waterdrop, a leading provider of innovative water filtration systems, is pleased to announce its partnership with The Water Project, a non-profit organization dedicated to providing reliable water projects in sub-Saharan African communities. Through this...

2024-07-26 16:42 1670

Grand exhibition of ancient Egyptian artifacts to open at Shanghai Museum

SHANGHAI, July 26, 2024 /PRNewswire/ -- A news report from english.shanghai.gov.cn: Photos by Gao Erqiang/chinadaily.com.cn The exhibition On Top of the Pyramid: The Civilization of Ancient Egypt opened to the publ...

2024-07-26 15:59 1752

China's innovative reform agenda: providing the world an alternative path to modernization

BEIJING, July 26, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: With the 3rd plenary session of the 20th CPC Central Committee outlining reforms to achieve modernization,Liu Qiao, dean of Peking University's Guanghua School of Management, told #ChinaPerspectives that China has devi...

2024-07-26 14:14 1518

Enjoy the Cultures and Landscapes of Gansu, Unveil the Magnificent Silk Road with Joint Hands

Successful Conclusion of Foreign Journalists' Tour to Gansu LANZHOU, China, July 26, 2024 /PRNewswire/ -- "The waters of the Yellow River come from upon Heaven, but they enter the world from here." Have you ever heard of this? In northwesternChina, the surging Yellow River flows through the L...

2024-07-26 13:08 2105

Tencent Music Entertainment Group Announces Management Change

SHENZHEN, China, July 26, 2024 /PRNewswire/ -- Tencent Music Entertainment Group ("TME", or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, today announced that Ms.Linlin Chen has tendered her resignation from her position as the Comp...

2024-07-26 12:00 3628

"Innovation Awards 2024 Nomination at Automechanika Frankfurt: Breakthroughs and Future of THINKCAR Tech"

ESCHBORN, Germany, July 25, 2024 /PRNewswire/ -- On July 18, 2024, the international expert jury of the Innovation Awards 2024 Nomination at Automechanika Frankfurt held a meeting. After strict evaluation, from 153 entries, THINKTOOL 399 in the field of AI&Digitalisation and THINKTOOL CE EVD in ...

2024-07-26 10:54 1478

Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China , July 25, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immuno...

2024-07-26 10:16 1796